Kalaris Therapeutics Inc (KLRS) has a market capitalization of $109.78M and trades at $5.87. The 52-week range is 2.14-11.88.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.1, Earnings Per Share (EPS) of $-2.85.
The stock has a beta of -0.14, operates in the Healthcare sector.
